- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Glucotrack, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 29.09. | GlucoTrack files to sell 20.06M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
| 29.09. | Glucotrack, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 15.09. | GlucoTrack stock tumbles after issuing $3.6M convertible note | 2 | Investing.com | ||
| 11.09. | Glucotrack, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 11.09. | Glucotrack, Inc.: Glucotrack to Participate in the Q3 Virtual Investor Summit | 3 | GlobeNewswire (USA) | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 05.09. | Glucotrack, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 15.08. | Glucotrack GAAP EPS of -$9.62 | 1 | Seeking Alpha | ||
| 14.08. | Glucotrack to submit long-term CGM implant for FDA IDE this year | 1 | MassDevice | ||
| 14.08. | Glucotrack, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 14.08. | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | 233 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| 06.08. | Cardiac electrophysiologist Hirsh joins Glucotrack's clinical team | 1 | Investing.com | ||
| 06.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Glucotrack, Inc.: Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology | 168 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people... ► Artikel lesen | |
| 31.07. | Glucotrack, Inc.: Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting | 1 | GlobeNewswire (USA) | ||
| 24.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 08.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Glucotrack, Inc.: Glucotrack Announces Repurchase of Series A Warrants | 1 | GlobeNewswire (USA) | ||
| 27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 882 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
| 25.06. | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | 3 | RTTNews |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,970 | -2,36 % | Eckert & Ziegler SCHOCKIERT Anleger: Könnte die Aktie am Montag komplett einbrechen - Das müssen Sie JETZT beachten! | ||
| SERNOVA BIOTHERAPEUTICS | 0,114 | +2,70 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz | EQS-News: SYNLAB
/ Schlagwort(e): Expansion
SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz
09.10.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,033 | +3,77 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting | -- Special Meeting to be held on September 26, 2025 --
SAN DIEGO, Sept. 9, 2025 /PRNewswire/ -- In an update to stockholders today, Evofem Biosciences, Inc.... ► Artikel lesen | |
| UNIDOC HEALTH | 0,120 | +0,17 % | Unidoc Health Corp: Unidoc arranges $1.5-million private placement | ||
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA | BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,306 | -5,56 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| QUIDELORTHO | 23,000 | +0,88 % | QuidelOrtho Corporation: QuidelOrtho Completes Debt Refinancing | SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic... ► Artikel lesen | |
| VERU | 3,910 | -8,64 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 158,00 | -0,35 % | 7 Analysts Have This To Say About Quest Diagnostics | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| SENSEONICS | 0,369 | +1,79 % | Senseonics Holdings, Inc.: Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update | Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October... ► Artikel lesen | |
| RADNET | 61,00 | 0,00 % | RadNet: Ist ein neues Allzeithoch möglich? |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,22 % bei einem Aktienkurs von 7,910 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.